Sun Pharmaceutical Industries Ltd

Integrated Filing — Corporate Governance (NSE XBRL)

Company Home Dashboard NSE Viewer

Filing Summary

Company
Sun Pharmaceutical Industries Limited
Symbol
SUNPHARMA
Quarter Ended
31-Mar-2026
Submission
New

General Disclosures

Advertisements As Per Regulation471
Yes
Annual Return As Provided Under Section92Of The Companies Act2013
Yes
Approval For Material Related Party Transactions
Yes
Approval Of The Board And Shareholders For Compensation Or Profit Sharing
Not Applicable
Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls
Yes
Board Composition
Yes
Code Of Conduct
Yes
Compliance Certificate
Yes
Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation
Yes
Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46
Yes
Credit Rating Or Revision In Credit Rating Obtained
Yes
Date Of End Of Financial Year
31-Mar-2026
Date Of End Of Reporting Period
31-Mar-2026
Date Of Signing
28-Apr-2026
Date Of Start Of Financial Year
01-Apr-2025
Designation Of Person
Company Secretary and Compliance Officer
Designation Of Person Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Annual Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Quartely Affirmations
Company Secretary and Compliance Officer
Details Of Agreements Entered Into With The Media Companies And Or Their Associates
Not Applicable
Details Of Business
Yes
Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy
Yes
Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30
Yes
Disclosure Of Related Party Transactions On Consolidated Basis
Yes
Disclosure Web Link Of Annual Return As Provided Under Section92Of The Companies Act2013Is Placed
https://sunpharma.com/annual-return/
Disclosure Web Link Of Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls Is Placed
https://sunpharma.com/quarterly-financials-transcripts-and-earnings-call-recordings/
Disclosure Web Link Of Company At Advertisements As Per Regulation471Is Placed
https://sunpharma.com/newspaper-advertisements/
Disclosure Web Link Of Company At Dividend Distribution Policy As Per Regulation43A1Is Placed
https://sunpharma.com/policies/
Disclosure Web Link Of Company At Materiality Policy As Per Sub Regulation4Regulation30Is Placed
https://sunpharma.com/policies/
Disclosure Web Link Of Company At Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity Is Placed
https://sunpharma.com/investors/annual-reports-of-subsidiary-companies/
Disclosure Web Link Of Company At Which Credit Rating Or Revision In Credit Rating Obtained Is Placed
https://sunpharma.com/investors/credit-rating/
Disclosure Web Link Of Company At Which Details Of Business Is Placed
https://sunpharma.com/about-us/
Disclosure Web Link Of Company At Which Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy Is Placed
https://sunpharma.com/policies/
Disclosure Web Link Of Company At Which Financial Results Is Placed
https://sunpharma.com/board-meeting-financial-results/
Disclosure Web Link Of Company At Which Policy For Determining Material Subsidiaries Is Placed
https://sunpharma.com/policies/
Disclosure Web Link Of Company At Which Policy On Dealing With Related Party Transactions Is Placed
https://sunpharma.com/policies/
Disclosure Web Link Of Company At Which Shareholding Pattern Is Placed
https://sunpharma.com/shareholding-pattern-76/
Disclosure Web Link Of Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation Is Placed
https://sunpharma.com/
Disclosure Web Link Of Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46Is Placed
https://sunpharma.com/
Disclosure Web Link Of Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30Is Placed
https://sunpharma.com/policies/
Disclosure Web Link Of Disclosures Under Sub Regulation8Of Regulation30Is Placed
https://sunpharma.com/disclosure-under-regulation-30/
Disclosure Web Link Of Memorandum Of Association And Articles Of Association Is Placed
https://sunpharma.com/wp-content/uploads/2023/08/SPIL-MOA-and-AOA.pdf
Disclosure Web Link Of Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet Is Placed
https://sunpharma.com/quarterly-financials-transcripts-and-earnings-call-recordings/ https://sunpharma.com/investors/investor-presentations/
Disclosure Web Link Of Secretarial Compliance Report Is Placed
https://sunpharma.com/secretarial-compliance-report/
Disclosures Under Sub Regulation8Of Regulation30
Yes
Dividend Distribution Policy As Per Regulation43A1
Yes
Employee Benefit Scheme Documents Framed In Terms Of SEBI Share Based Employee Benefits And Sweat Equity Regulations2021
Not Applicable
Fees Or Compensation
Yes
Financial Results
Yes
Is SCORESID Available
Yes
ISIN
INE044A01036
Market Capitalisation As Per Immediate Previous Financial Year
Top 100 listed entities
Materiality Policy As Per Sub Regulation4Regulation30
Yes
Memorandum Of Association And Articles Of Association
Yes
Minimum Information
Yes
Name Of Signatory
Anoop Deshpande
Name Of Signatory Affirmations
Anoop Deshpande
Name Of Signatory For Annual Affirmations
Anoop Deshpande
Name Of Signatory For Quartely Affirmations
Anoop Deshpande
Name Of The Company
Sun Pharmaceutical Industries Limited
New Name And The Old Name Of The Listed Entity
Not Applicable
Number Of Cyber Security Incidence Or Breaches Or Loss Of Data Event Occurred During The Quarter
1
Other Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity
Yes
Place
Mumbai
Plans For Orderly Succession For Appointments
Yes
Policy For Determining Material Subsidiaries
Yes
Policy For Related Party Transaction
Yes
Policy On Dealing With Related Party Transactions
Yes
Reason For Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Not Applicable To The Entity
There is nothing to be reported.
Recommendation Of Board
Yes
Reporting Quarter
Yearly
Review Of Compliance Reports
Yes
Risk Assessment And Management
Yes
Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet
Yes
SCORES Registration ID
S00607
Scrip Code
524715
Secretarial Compliance Report
Yes
Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity
Yes
Shareholding Pattern
Yes
Statements Of Deviations Or Variations As Specified In Regulation32
Not Applicable
Symbol
SUNPHARMA
The Listed Entity Has Approved Material Subsidiary Policy And The Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity Have Been Complied
Yes
Type Of Company
Equity
Type Of Submission
Original
Vacancies In Respect Key Managerial Personnel
Yes
Vigil Mechanism
Yes
Whether As Per Sub Regulation2ba Of Regulation27Of SEBILODR There Has Been Cyber Security Incidents During The Quarter
Yes
Whether Part A Of Annexure I Of The SEBI Circular Dated31December2024Related To Compliance Report On Corporate Governance Is Applicable To The Entity
Yes
Whether Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Applicable To The Entity
No

Additional Disclosures

Entry D_CyberSecurityIncidenceOrBreachesOrLossOfDataEvent1
Brief Details Of Cyber Security Incidence Or Breaches Or Loss Of Data Event
A third‑party service provider reported a cybersecurity incident affecting its systems, which resulted in certain data relating to a subsidiary company being identified as available on the dark web. Upon becoming aware of the incident, the service provider initiated appropriate containment and remediation measures in accordance with its incident response framework. The matter was assessed in coordination with the service provider, and necessary actions have been taken to mitigate potential risks and prevent recurrence. There has been no material impact on the operations of the Company or the Group arising from this incident. The incident occured in December 2025 and was reported to the Company on 19 January 2026.
Date Of Cyber Security Incidence Or Breaches Or Loss Of Data Event
19-Jan-2026
Entry D_MeetingBOD1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit10
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit11
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit12
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit13
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit14
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit4
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit5
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit6
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit7
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit8
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit9
Whether Requirement Of Quorum Met
Yes
Official NSE disclosure viewer

If the viewer does not load, use the NSE Viewer button above to open it in a new tab.

Board Composition — Entity Disclosures

Disclosure Of Notes On Composition Of Board Of Directors Explanatory Text Block
Dr.Pawan Kumar Goenka is the Lead Independent Director of the Company
The Composition Of Board Of Directors Is In Terms Of Sebi Regulations2015
Yes
Chairperson Related to MD / CEO
No
Regular Chairperson
Yes

Composition of Board of Directors

SrTitleDirectorPANDINCategory 1Category 2Category 3Date of BirthDisqualifiedStatusSpecial ResolutionSpecial Resolution DateInitial AppointmentRe-appointmentTenure (months)Listed DirectorshipsIndependent DirectorshipsAudit / Stakeholder MembershipsAudit / Stakeholder Chair Posts
1MrDilip Shantilal Shanghvi******00005588Executive DirectorChairperson related to Promoter18-Oct-1955NoActiveNot Applicable01-Mar-199301-Sep-20252000
2MrKirti Wardhaman Ganorkar******10620142Executive DirectorNot ApplicableMD10-Feb-1967NoActiveNot Applicable01-Sep-20251010
3MrPawan Kumar Goenka******00254502Non-Executive - Independent DirectorNot Applicable23-Sep-1954NoActiveNot Applicable21-May-202121-May-2021592230
4MrGautam Bhailal Doshi******00004612Non-Executive - Independent DirectorNot Applicable23-Dec-1952NoActiveYes29-Aug-202225-May-201825-May-2023942253
5MsRama Bijapurkar******00001835Non-Executive - Independent DirectorNot Applicable12-Mar-1957NoActiveNot Applicable21-May-202121-May-2021594441
6MrRolf Hoffmann******10200311Non-Executive - Independent DirectorNot Applicable01-May-1959NoActiveNot Applicable15-Jun-202315-Jun-2023341100
7MrAalok Dilip Shanghvi******01951829Executive DirectorNot Applicable21-Sep-1984NoActiveNot Applicable01-Jun-20231010
8MsVidhi Dilip Shanghvi******06497350Executive DirectorNot Applicable11-Oct-1987NoActiveNot Applicable22-May-20252020

Committee Disclosures

Entry CompComit122
Date of Appointment
27-May-2021
Entry CompComit123
Date of Appointment
27-May-2022
Entry CompComit124
Date of Appointment
29-May-2014
Entry CompComit125
Date of Appointment
31-Jul-2025
Entry CompComit14
Date of Appointment
25-May-2018
Entry CompComit15
Date of Appointment
27-May-2021
Entry CompComit16
Date of Appointment
31-Mar-2025
Entry CompComit41
Date of Appointment
27-May-2021
Entry CompComit42
Date of Appointment
14-Aug-2018
Entry CompComit43
Date of Appointment
01-Nov-2023
Entry CompComit44
Date of Appointment
31-Jul-2025
Entry CompComit68
Date of Appointment
14-Aug-2018
Entry CompComit69
Date of Appointment
27-May-2022
Entry CompComit70
Date of Appointment
31-Jul-2025
Entry CompComit71
Date of Appointment
01-Sep-2025
Entry CompComit95
Date of Appointment
29-May-2022
Entry CompComit96
Date of Appointment
20-May-2021
Entry CompComit97
Date of Appointment
27-Sep-2014
Entry CompComit98
Date of Appointment
31-Jul-2025
Entry CompComit99
Date of Appointment
22-May-2025
Entry MainD
Composition And Role Of Risk Management Committee
Yes
Composition Of Audit Committee
Yes
Composition Of Nomination And Remuneration Committee
Yes
Composition Of Stakeholder Relationship Committee
Yes
Composition Of Various Committees Of Board Of Directors
Yes
Disclosure Web Link Of Company At Which Composition Of Various Committees Of Board Of Directors Is Placed
https://sunpharma.com/committees-of-the-board/
Memberships In Committees
Yes
Prior Or Omnibus Approval Of Audit Committee For All Related Party Transactions
Yes
Risk Management Committee
Yes
Role Of Audit Committee And Information To Be Reviewed By The Audit Committee
Yes
Role Of Nomination And Remuneration Committee
Yes
Role Of Stakeholders Relationship Committee
Yes
The Committee Members Have Been Made Aware Of Their Powers Role And Responsibilities As Specified In Sebi Regulations2015
Yes
The Composition Of Audit Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Nomination And Remuneration Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Risk Management Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Stakeholders Relationship Committee Committee Is In Terms Of Sebi Regulations2015
Yes
Whether The Audit Committee Has A Regular Chairperson
Yes
Whether The Corporate Social Responsibility Committee Has A Regular Chairperson
Yes
Whether The Nomination And Remuneration Committee Has A Regular Chairperson
Yes
Whether The Risk Management Committee Has A Regular Chairperson
Yes
Whether The Stakeholders Relationship Committee Has A Regular Chairperson
Yes

Audit Committee

Additional Position
Chairperson
Director DIN
00004612
Member Name
Gautam Bhailal Doshi
Notes
Mr.Gautam Doshi was appointed as Member of Audit Committee with effect from 25 May 2018 and was appointed as the Chairperson of Audit Committee with effect from 27 September 2018.
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
00254502
Member Name
Pawan Kumar Goenka
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
00001835
Member Name
Rama Bijapurkar
Position
Non-Executive - Independent Director

Audit Committee

Audit Committee

Audit Committee

Corporate Social Responsibility Committee

Additional Position
Chairperson
Director DIN
00001835
Member Name
Rama Bijapurkar
Notes
Ms. Rama Bijapurkar was appointed as a Member of CSR Committee with effect from 27 May 2021 and appointed as the Chairperson of CSR Committee with effect from 26 May 2023.
Position
Non-Executive - Independent Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
00254502
Member Name
Pawan Kumar Goenka
Position
Non-Executive - Independent Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
00005588
Member Name
Dilip Shantilal Shanghvi
Notes
Mr. Dilip Shanghvi served as a Chairperson of CSR Committee upto 26 May 2023 and thereafter he continues to be a Member.
Position
Executive Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
06497350
Member Name
Vidhi Dilip Shanghvi
Position
Executive Director

Corporate Social Responsibility Committee

Corporate Social Responsibility Committee

Nomination and remuneration committee

Additional Position
Chairperson
Director DIN
00254502
Member Name
Pawan Kumar Goenka
Notes
Dr.Pawan Goenka, Lead Independent Director, was appointed as a Member of Nomination & Remuneration Committee with effect from 27 May 2021 and was appointed as the Chairperson of Nomination & Remuneration Committee with effect from 1 September 2021.
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
00004612
Member Name
Gautam Bhailal Doshi
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
10200311
Member Name
Rolf Hoffmann
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
00005588
Member Name
Dilip Shantilal Shanghvi
Position
Executive Director

Nomination and remuneration committee

Nomination and remuneration committee

Other Committee

Additional Position
Chairperson
Director DIN
00004612
Member Name
Gautam Bhailal Doshi
Name Of Other Committee
Corporate Governance and ESG Committee
Position
Non-Executive - Independent Director

Other Committee

Additional Position
Member
Director DIN
00254502
Member Name
Pawan Kumar Goenka
Name Of Other Committee
Corporate Governance and ESG Committee
Position
Non-Executive - Independent Director

Other Committee

Additional Position
Member
Director DIN
10620142
Member Name
Kirti Wardhaman Ganorkar
Name Of Other Committee
Corporate Governance and ESG Committee
Position
Executive Director

Other Committee

Additional Position
Member
Director DIN
00000000
Member Name
Jayashree Satagopan
Name Of Other Committee
Corporate Governance and ESG Committee
Notes
The designation of the Non-Board Member in the Committee is Chief Financial Officer and is to be mentioned in the category of the Composition of Corporate Governance and ESG Committee as per NSE FAQ. However, there is a validation error while mentioning the same therefore, we have entered Member.
Position
Member

Other Committee

Additional Position
Member
Director DIN
00000000
Member Name
Anoop Deshpande
Name Of Other Committee
Corporate Governance and ESG Committee
Notes
The designation of the Non-Board Member in the Committee is Company Secretary and Compliance Officer and is to be mentioned in the category of the Composition of Corporate Governance and ESG Committee as per NSE FAQ. However, there is a validation error while mentioning the same therefore, we have entered Member.
Position
Member

Other Committee

Name Of Other Committee
Corporate Governance and ESG Committee

Other Committee

Name Of Other Committee
Corporate Governance and ESG Committee

Other Committee

Name Of Other Committee
Corporate Governance and ESG Committee

Risk Management Committee

Additional Position
Chairperson
Director DIN
00254502
Member Name
Pawan Kumar Goenka
Notes
Dr. Pawan Goenka, Lead Independent Director, was appointed as a Member of Risk Management Committee with effect from 29 May 2022 and appointed as a Chairperson of the Risk Management Committee with effect from 1 August 2024
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Member
Director DIN
00004612
Member Name
Gautam Bhailal Doshi
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Member
Director DIN
00005588
Member Name
Dilip Shantilal Shanghvi
Notes
Mr. Dilip Shanghvi served as a Chairperson of Risk Management Committee upto 1 August 2024 and thereafter he continues to be a Member.
Position
Executive Director

Risk Management Committee

Additional Position
Member
Director DIN
01951829
Member Name
Aalok Dilip Shanghvi
Position
Executive Director

Risk Management Committee

Additional Position
Member
Director DIN
00000000
Member Name
Jayashree Satagopan
Notes
The designation of the Non-Board Member in the Committee is Chief Financial Officer and is to be mentioned in the category of the Composition of Risk Management Committee as per NSE FAQ. However, there is a validation error while mentioning the same therefore, we have entered Member.
Position
Member

Risk Management Committee

Risk Management Committee

Stakeholders Relationship Committee

Additional Position
Chairperson
Director DIN
00004612
Member Name
Gautam Bhailal Doshi
Notes
Mr.Gautam Doshi was appointed as a Member of Stakeholders Relationship Committee with effect from 14 August 2018 and appointed as the Chairperson of Stakeholders Relationship Committee with effect from 27 September 2018.
Position
Non-Executive - Independent Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
00254502
Member Name
Pawan Kumar Goenka
Position
Non-Executive - Independent Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
01951829
Member Name
Aalok Dilip Shanghvi
Position
Executive Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
10620142
Member Name
Kirti Wardhaman Ganorkar
Position
Executive Director

Stakeholders Relationship Committee

Stakeholders Relationship Committee

Entry MainD
Gap Between The Meetings Of The Risk Management Committee
Yes
Meeting Of Audit Committee
Yes
Meeting Of Board Of Directors
Yes
Meeting Of Independent Directors
Yes
Meeting Of Nomination And Remuneration Committee
Yes
Meeting Of Risk Management Committee
Yes
Meeting Of Stakeholders Relationship Committee
Yes
Quorum Of Board Meeting
Yes
Quorum Of Nomination And Remuneration Committee Meeting
Yes
Quorum Of Risk Management Committeemeeting
Yes
The Meetings Of The Board Of Directors And The Above Committees Have Been Conducted In The Manner As Specified In Sebi Regulations2015
Yes
Entry MeetingBOD1
Dates Of Meeting In The Previous Quarter
05-Nov-2025
Number Of Directors Present In Meeting Of Board Of Directors
8
Number Of Independent Directors Attending The Meeting
4
Total Number Of Directors As On Date Of The Meeting
8
Entry MeetingBOD2
Dates Of Meeting If Any In The Relevant Quarter
31-Jan-2026
Maximum Gap Between Any Two Consecutive Meetings
86
Number Of Directors Present In Meeting Of Board Of Directors
8
Number Of Independent Directors Attending The Meeting
4
Total Number Of Directors As On Date Of The Meeting
8
Entry MeetingBOD3
Dates Of Meeting If Any In The Relevant Quarter
27-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
54
Number Of Directors Present In Meeting Of Board Of Directors
8
Number Of Independent Directors Attending The Meeting
4
Total Number Of Directors As On Date Of The Meeting
8
Entry MeetingComit1
Dates Of Meeting Of The Committee In The Previous Quarter
05-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit10
Dates Of Meeting Of The Committee In The Previous Quarter
04-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit11
Dates Of Meeting Of The Committee In The Relevant Quarter
30-Jan-2026
Maximum Gap Between Any Two Consecutive Meetings
86
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit12
Dates Of Meeting Of The Committee In The Previous Quarter
04-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
2
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit13
Dates Of Meeting Of The Committee In The Relevant Quarter
30-Jan-2026
Maximum Gap Between Any Two Consecutive Meetings
86
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
2
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit14
Dates Of Meeting Of The Committee In The Relevant Quarter
23-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
51
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
2
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit2
Dates Of Meeting Of The Committee In The Relevant Quarter
30-Jan-2026
Maximum Gap Between Any Two Consecutive Meetings
85
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit3
Dates Of Meeting Of The Committee In The Relevant Quarter
23-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
51
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
2
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit4
Dates Of Meeting Of The Committee In The Previous Quarter
04-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit5
Dates Of Meeting Of The Committee In The Relevant Quarter
31-Jan-2026
Maximum Gap Between Any Two Consecutive Meetings
87
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit6
Dates Of Meeting Of The Committee In The Previous Quarter
04-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit7
Dates Of Meeting Of The Committee In The Relevant Quarter
30-Jan-2026
Maximum Gap Between Any Two Consecutive Meetings
86
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit8
Dates Of Meeting Of The Committee In The Previous Quarter
04-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
1
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit9
Dates Of Meeting Of The Committee In The Relevant Quarter
30-Jan-2026
Maximum Gap Between Any Two Consecutive Meetings
86
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
1
Total Number Of Directors As On Date Of The Meeting
4
Entry MainD
Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances
Yes
Disclosure Web Link Of Company At Which Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances Is Placed
https://sunpharma.com/contact/
Disclosure Web Link Of Company At Which Email Address For Grievance Redressal And Other Relevant Details Is Placed
https://sunpharma.com/contact/
Email Address For Grievance Redressal And Other Relevant Details
Yes
No Of Investor Complaints Disposed Off During The Period
12
No Of Investor Complaints During The Period
-1
No Of Investor Complaints Received During The Period
11
Whether Part B Of Annexure I Of The SEBI Circular Dated31December2024Related To Investor Grievance Redressal Report Is Applicable To The Entity
Yes
Entry MainI
No Of Investor Complaints
2
Entry PY_I
No Of Investor Complaints
3
Composition Of Board Of Directors Of Unlisted Material Subsidiary
Yes
Reason For Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Not Applicable To The Entity
There is nothing to be reported.
Whether Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Applicable To The Entity
No
Entry I_OngoingTaxLitigationsOrDisputes1
Current Status
Ongoing
Date of Initiation
23-Jan-2020
Opposing Party
DCIT - Circle 2(1)(1) - Baroda
Status (Previous Disclosure)
Adjustment to Income made during assessment under section 143(3) of the Income-tax Act
Entry I_OngoingTaxLitigationsOrDisputes2
Current Status
Ongoing
Date of Initiation
25-Oct-2021
Opposing Party
DCIT - Circle 2(1)(1) - Baroda
Status (Previous Disclosure)
Adjustment to Income made during assessment under section 143(3) of the Income-tax Act
Entry I_OngoingTaxLitigationsOrDisputes3
Current Status
Closed by an order significantly in favour of the Company
Date of Initiation
29-Oct-2022
Opposing Party
DCIT - Circle 2(1)(1) - Baroda
Status (Previous Disclosure)
Adjustment to Income made during assessment under section 143(3) of the Income-tax Act
Entry I_OngoingTaxLitigationsOrDisputes4
Current Status
Ongoing
Date of Initiation
03-Jul-2020
Opposing Party
Commissioner - Service Tax, Mumbai
Status (Previous Disclosure)
Service tax on Out of Court Settlement Expenses
Entry MainD
Whether Part E Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Updates To Ongoing Tax Litigations Or Disputes Is Applicable To The Entity
Yes
Reason For Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Not Applicable To The Entity
There is nothing to be reported.
Whether Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Applicable To The Entity
No